#ASABreakpoint
Diagnostic Photo #Quiz
🧩 #Unvaccinated Infant
A 4-month-old unvaccinated infant with severe cough + apnoea.
Lab results reveal something unexpected.
Any guesses on the culprit pathogen?
Find the answer in #Issue48: www.asainc.net.au/newsletters/
#MicroSKy #IDsky #AMSsky

#ASABreakpoint
In vitro, combos look powerful. In practice? Not always.
@angelahuttner.bsky.social reminds us “first, do no harm” Trials show limited benefit + higher toxicity
Are we relying too much on combo therapy in real-world care?
Read: www.asainc.net.au/newsletters/
@gardp.bsky.social #REVIVE

#ASABreakpoint
#AGAR 2024 Report 📊 #Keyfindings
📈 #ESBL E. coli & Klebsiella are increasing
🔬 ~50% of E. faecium are vancomycin-resistant
🦘 Australia still compares well globally
How should we use these numbers to shape practice?
Read more here: www.asainc.net.au/newsletters/
#MicroSky #IDSky

#ASABreakpoint
#AUSCAST guidance on aminopenicillin breakpoint 💊
That means big changes for how labs report results, especially when distinguishing #cystitis from systemic #UTIs

#Implementation won’t be easy. How’s your lab handling it?
Read more here: www.asainc.net.au/newsletters/
#IDsky #AMSsky

#ASABreakpoint #InTheSpotlight
Dr Chris Robson’s PhD highlights how we can improve outcomes; from better #antimicrobial dosing to adopting multidisciplinary care models.
Should every centre have an MDT endocarditis team?
#infectiveendocarditis #IDSky #AMSsky #MicroSky